Search Results - "Teng, Nelson N.H"

Targeting Foxm1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer by Westhoff, Gina L, Chen, Yi, Teng, Nelson N H

“…Aberrantly activated FOXM1 (forkhead box protein M1) leading to uncontrolled cell proliferation and dysregulation of FOXM1 transcription network occurs in 84%…”
Get more information

The Omentum and omentectomy in epithelial ovarian cancer: A reappraisal Part I - Omental function and history of omentectomy by Arie, Alon Ben, McNally, Leah, Kapp, Daniel S, Teng, Nelson N.H

“…Abstract Objective This article reviews the literature concerning the function of the omentum and how omentectomy came to be part of the staging and treatment…”
Get full text

The omentum and omentectomy in epithelial ovarian cancer: A reappraisal by Arie, Alon Ben, McNally, Leah, Kapp, Daniel S, Teng, Nelson N.H

“…Abstract Objective This article reviews the literature concerning the role of omentectomy in the staging and treatment of clinically apparent early stage…”
Get full text

Squamous cell carcinoma arising from mature cystic teratoma of the ovary by Chiang, An-Jen, La, Victor, Peng, Jiaqi, Yu, Ken-Jen, Teng, Nelson N H

“…Squamous cell carcinoma (SCC) is the most common type of malignant transformation in mature cystic teratoma (MCT) of the ovary. The SCC is difficult to…”
Get more information

Differentiating between borderline and invasive malignancies in ovarian tumors using a multivariate logistic regression model by Chen, Jiabin, Chang, Chung, Huang, Hung-Chi, Chung, Yu-Che, Huang, Huan-Jung, Liou, Wen Shiung, Chiang, An Jen, Teng, Nelson N.H

“…Abstract Objective The objective of this study was to build a model to differentiate between borderline and invasive ovarian tumors. Materials and Methods We…”
Get full text

Targeting FOXM1 Improves Cytotoxicity of Paclitaxel and Cisplatinum in Platinum-Resistant Ovarian Cancer by Westhoff, Gina L, Chen, Yi, Teng, Nelson N H

“…Aberrantly activated FOXM1 (forkhead box protein M1) leading to uncontrolled cell proliferation and dysregulation of FOXM1 transcription network occurs in 84%…”
Get more information

In silico investigation of FOXM1 binding and novel inhibitors in epithelial ovarian cancer by Chen, Yi, Ruben, Eliza A., Rajadas, Jayakumar, Teng, Nelson N.H.

“…[Display omitted] Using TCGA database, we had demonstrated that aberrantly activated Forkhead box M1 (FOXM1) correlates to worse overall survival in a subgroup…”
Get full text

The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients by Chiang, An-Jen, Yu, Ken-Jen, Chao, Kuan-Chong, Teng, Nelson N.H

“…Abstract Objective To describe and review the incidence of para-aortic (PA) nodal metastasis in completely staged endometrial cancer patients who are negative…”
Get full text

Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer by Chen, Yi, Bieber, Marcia M., Teng, Nelson N.H.

Get full text

Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance by Urban, Renata R., MD, Teng, Nelson N.H., MD, PhD, Kapp, Daniel S., MD, PhD

“…We report a case of uterine cancer and invasive cervical cancer, detected incidentally during the female-to-male sex reassignment surgery. The management of…”
Get full text

Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database by McNally, Leah, Teng, Nelson N H, Kapp, Daniel S, Karam, Amer

“…Although omentectomy is part of the staging and treatment of epithelial ovarian cancer (EOC), its performance in a patient with a grossly normal…”
Get more information

Wnt and hedgehog gene pathway expression in serous ovarian cancer by Schmid, Seraina, Bieber, Marcia, Zhang, Fang, Zhang, Mallory, He, Biao, Jablons, David, Teng, Nelson N H

“…Ovarian cancer has very heterogeneous histological classification, and response to therapy of the same grade and type varies. We studied genes in the Wnt and…”
Get more information

Taxol-oligoarginine conjugates overcome drug resistance in-vitro in human ovarian carcinoma by Wender, Paul A, Galliher, Wesley C, Bhat, Neelima M, Pillow, Thomas H, Bieber, Marcia M, Teng, Nelson N.H

“…Abstract Objective Multidrug resistance is the major cause of failure of many chemotherapeutic agents. While resistance can arise from several factors, it is…”
Get full text

Leukemia Inhibitory Factor Downregulates Human Papillomavirus-16 Oncogene Expression and Inhibits the Proliferation of Cervical Carcinoma Cells by Bay, Joseph M., Patterson, Bruce K., Teng, Nelson N. H.

“…The constitutive proliferation and resistance to differentiation and apoptosis of neoplastic cervical cells depend on sustained expression of human…”
Get full text

Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy by Smith, R S, Kapp, D S, Chen, Q, Teng, N N

“…To evaluate the treatment outcomes in patients with optimally debulked Stage III and IV endometrial adenocarcinoma (ACA) or Stages I-IV uterine papillary…”
Get more information

Acute postoperative thrombotic thrombocytopenic purpura following hysterectomy and lymphadenectomy for endometrial cancer by Hamilton, Chad A, Kao, Jelena M, Coutre, Steven E, Teng, Nelson N.H

“…Abstract Background Thrombotic thrombocytopenic purpura (TTP) in the acute postoperative setting is a recently recognized syndrome that, similar to classic or…”
Get full text

Mesonephric adenocarcinoma of the cervix: A case report and review of the literature by Yap, O.W. Stephanie, Hendrickson, Michael R., Teng, Nelson N.H., Kapp, Daniel S.

“…Malignant mesonephric tumor arising in the uterine cervix is an exceedingly uncommon variant of cervical adenocarcinoma with only 30 well-documented cases in…”
Get full text

Safety and efficacy of lenalidomide (Revlimid®) in recurrent ovarian and primary peritoneal carcinoma by Zhang, Mallory M, Chan, John K, Husain, Amreen, Guo, Hong-Yan, Teng, Nelson N.H

“…Abstract Objectives To conduct a phase I trial to determine the safety and toxicity profile of a novel immunomodulatory drug, lenalidomide, in recurrent…”
Get full text

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin: A Randomized, Double-Blind, Placebo-Controlled Trial by Ziegler, Elizabeth J, Fisher, Charles J, Sprung, Charles L, Straube, Richard C, Sadoff, Jerald C, Foulke, Garrett E, Wortel, Cornelis H, Fink, Mitchell P, Dellinger, R. Phillip, Teng, Nelson N.H, Allen, I. Elaine, Berger, Harvey J, Knatterud, Genell L, LoBuglio, Albert F, Smith, Craig R

“…Septicemia is a leading cause of morbidity and mortality among hospitalized patients. There are approximately 400,000 cases each year in the United States, and…”
Get full text

Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma by Kondrashova, Olga, Nguyen, Minh, Shield-Artin, Kristy, Tinker, Anna V, Teng, Nelson N H, Harrell, Maria I, Kuiper, Michael J, Ho, Gwo-Yaw, Barker, Holly, Jasin, Maria, Prakash, Rohit, Kass, Elizabeth M, Sullivan, Meghan R, Brunette, Gregory J, Bernstein, Kara A, Coleman, Robert L, Floquet, Anne, Friedlander, Michael, Kichenadasse, Ganessan, O'Malley, David M, Oza, Amit, Sun, James, Robillard, Liliane, Maloney, Lara, Bowtell, David, Giordano, Heidi, Wakefield, Matthew J, Kaufmann, Scott H, Simmons, Andrew D, Harding, Thomas C, Raponi, Mitch, McNeish, Iain A, Swisher, Elizabeth M, Lin, Kevin K, Scott, Clare L

“…High-grade epithelial ovarian carcinomas containing mutated or ( ) homologous recombination (HR) genes are sensitive to platinum-based chemotherapy and PARP…”
Get more information